147 related articles for article (PubMed ID: 6363411)
1. Human malaria parasite adenosine deaminase. Characterization in host enzyme-deficient erythrocyte culture.
Daddona PE; Wiesmann WP; Lambros C; Kelley WN; Webster HK
J Biol Chem; 1984 Feb; 259(3):1472-5. PubMed ID: 6363411
[TBL] [Abstract][Full Text] [Related]
2. Adenosine deaminase from deoxycoformycin-sensitive and -resistant rat hepatoma cells. Purification and characterization.
Hunt SW; Hoffee PA
J Biol Chem; 1982 Dec; 257(23):14239-44. PubMed ID: 6815190
[TBL] [Abstract][Full Text] [Related]
3. Expression of human malaria parasite purine nucleoside phosphorylase in host enzyme-deficient erythrocyte culture. Enzyme characterization and identification of novel inhibitors.
Daddona PE; Wiesmann WP; Milhouse W; Chern JW; Townsend LB; Hershfield MS; Webster HK
J Biol Chem; 1986 Sep; 261(25):11667-73. PubMed ID: 3091593
[TBL] [Abstract][Full Text] [Related]
4. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
Franco R; Hoyle CH; Centelles JJ; Burnstock G
Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
[TBL] [Abstract][Full Text] [Related]
5. Adenosine deaminase in malaria infected erythrocytes: unique parasite enzyme presents a new therapeutic target.
Wiesmann WP; Webster HK; Lambros C; Kelley WN; Daddona PE
Prog Clin Biol Res; 1984; 165():325-42. PubMed ID: 6334315
[No Abstract] [Full Text] [Related]
6. The deamination of adenosine and adenosine monophosphate in Plasmodium falciparum-infected human erythrocytes: in vitro use of 2'deoxycoformycin and AMP deaminase-deficient red cells.
Roth E; Ogasawara N; Schulman S
Blood; 1989 Aug; 74(3):1121-5. PubMed ID: 2665862
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of adenosine deaminase from a genetically enriched mouse cell line.
Ingolia DE; Yeung CY; Orengo IF; Harrison ML; Frayne EG; Rudolph FB; Kellems RE
J Biol Chem; 1985 Oct; 260(24):13261-7. PubMed ID: 3902813
[TBL] [Abstract][Full Text] [Related]
9. Levels of adenosine deaminase AMP deaminase, and adenylate kinase in cultured human lymphoblast lines: exquisite sensitivity of AMP deaminase to adenosine deaminase inhibitors.
Fishbein WN; Davis JI; Winkert JW; Strong DM
Biochem Med; 1981 Dec; 26(3):377-86. PubMed ID: 6277304
[No Abstract] [Full Text] [Related]
10. Adenosine deaminase in malaria infection: effect of 2'-deoxycoformycin in vivo.
Webster HK; Wiesmann WP; Pavia CS
Adv Exp Med Biol; 1984; 165 Pt A():225-9. PubMed ID: 6609525
[No Abstract] [Full Text] [Related]
11. Isolation of mutant adenosine deaminase by coformycin affinity chromatography.
Danton MJ; Coleman MS
Anal Biochem; 1986 Nov; 159(1):233-9. PubMed ID: 3492941
[TBL] [Abstract][Full Text] [Related]
12. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
13. Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse.
Ho DH; Pincus C; Carter CJ; Benjamin RS; Freireich EJ; Bodey GP
Cancer Treat Rep; 1980; 64(4-5):629-33. PubMed ID: 6968622
[TBL] [Abstract][Full Text] [Related]
14. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
Ratech H; Thorbecke GJ; Hirschhorn R
Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
[No Abstract] [Full Text] [Related]
15. Structural and metabolic specificity of methylthiocoformycin for malarial adenosine deaminases.
Ho MC; Cassera MB; Madrid DC; Ting LM; Tyler PC; Kim K; Almo SC; Schramm VL
Biochemistry; 2009 Oct; 48(40):9618-26. PubMed ID: 19728741
[TBL] [Abstract][Full Text] [Related]
16. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
Hirschhorn R; Ratech H
Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
[No Abstract] [Full Text] [Related]
17. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
Smith CM; Henderson JF
Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
[TBL] [Abstract][Full Text] [Related]
18. Tight binding inhibitors--VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and sarcoma 180 cells.
Rogler-Brown T; Agarwal RP; Parks RE
Biochem Pharmacol; 1978; 27(19):2289-96. PubMed ID: 569482
[No Abstract] [Full Text] [Related]
19. Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course.
Coleman MS; Danton MJ; Philips A
Ann N Y Acad Sci; 1985; 451():54-65. PubMed ID: 3878121
[No Abstract] [Full Text] [Related]
20. Increased adenosine deaminase synthesis and messenger RNA activity in deoxycoformycin-resistant cells.
Hunt SW; Hoffee PA
J Biol Chem; 1983 Jan; 258(1):41-4. PubMed ID: 6600234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
